Biological Potential of Extremophilic Filamentous Fungi for the Production of New Compounds with Antimicrobial Effect

Antimicrobial resistance represents one of the most critical public health challenges of the 21st century. The emergence of multidrug resistance (MDR) in bacterial and fungal pathogens to diverse chemical agents severely impedes the effective treatment of diseases such as cancer and systemic infecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladislava Dishliyska, Jeny Miteva-Staleva, Yana Gocheva, Galina Stoyancheva, Lyudmila Yovchevska, Radoslav Abrashev, Boryana Spasova, Maria Angelova, Ekaterina Krumova
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Fermentation
Subjects:
Online Access:https://www.mdpi.com/2311-5637/11/6/347
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antimicrobial resistance represents one of the most critical public health challenges of the 21st century. The emergence of multidrug resistance (MDR) in bacterial and fungal pathogens to diverse chemical agents severely impedes the effective treatment of diseases such as cancer and systemic infections. The rapid escalation of microbial resistance underscores the urgent need for the discovery of novel antimicrobial agents and innovative approaches to drug development. In both clinical and industrial contexts, the identification of new antibiotics and antifungals remains pivotal for pathogen control. Current research efforts focus on the development of alternative formulations that offer high efficacy, reduced resistance potential, minimal side effects, and synergistic interactions, particularly those derived from natural sources. Filamentous fungi originating from extreme environments have evolved to thrive under harsh conditions, making them promising reservoirs of bioactive metabolites with unique structural and functional properties. These fungi exhibit potent antimicrobial activity through diverse mechanisms that disrupt essential cellular processes in pathogens. Despite their remarkable potential, the bioprospecting of extremophilic filamentous fungi for drug development remains underexplored. This highlights the necessity for expanded research into the efficacy and safety of their derived compounds. This review aims to emphasize the capacity of extremophilic fungi to produce antimicrobial agents, elucidate resistance mechanisms, characterize fungal bioactive extracts, and analyze their molecular actions in the context of their extreme ecological niches.
ISSN:2311-5637